Abstract
Sympatholytic drugs are agents that decrease the activity of the sympathetic nervous system (SNS). This is accomplished via a variety of mechanisms that most commonly include adrenergic receptor blockade (e.g., α and β adrenergic receptor antagonism) as well as specific receptor agonism (i.e., α2 adrenergic receptor agonism) (1). The SNS signal, however, may be blocked in other ways (e.g., peripheral ganglionic blockade) (2).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Suggested Readings
Blaudszun G, Lysakowski C, Elia N, Tramer MR. Effect of perioperative systemic alpha2 agonists on postoperative morphine consumption and pain intensity: systematic review and meta-analysis of randomized controlled trials. Anesthesiology. 2012;116(6):1312–22.
Chan AK, Cheung CW, Chong YK. Alpha-2 agonists in acute pain management. Expert Opin Pharmacother. 2010;11(17):2849–68.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Khelemsky, Y., Gritsenko, K., Curatolo, C. (2017). Sympatholytic Agents. In: Yong, R., Nguyen, M., Nelson, E., Urman, R. (eds) Pain Medicine. Springer, Cham. https://doi.org/10.1007/978-3-319-43133-8_54
Download citation
DOI: https://doi.org/10.1007/978-3-319-43133-8_54
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-43131-4
Online ISBN: 978-3-319-43133-8
eBook Packages: MedicineMedicine (R0)